<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <summaries>
      <billSummaries>
        <item>
          <actionDate>2015-04-29</actionDate>
          <updateDate>2015-04-29T04:00:00Z</updateDate>
          <lastSummaryUpdateDate>2015-09-03T14:10:25Z</lastSummaryUpdateDate>
          <name>Introduced in Senate</name>
          <actionDesc>Introduced in Senate</actionDesc>
          <versionCode>00</versionCode>
          <text><![CDATA[<p><b>Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015</b></p> <p>This bill requires the Department of Health and Human Services (HHS), in cooperation with the Department of Veterans Affairs, the Department of Defense, and the Drug Enforcement Administration, to convene a Pain Management Best Practices Inter-Agency Task Force to develop and study best practices for pain management and prescription of pain medication.</p> <p>The Harold Rogers Prescription Drug Monitoring Program is extended through FY2020. The Government Accountability Office must evaluate the effectiveness of this program in reducing prescription drug abuse and any corresponding increase or decrease in the use of heroin.</p> <p>This bill amends the Omnibus Crime Control and Safe Streets Act of 1968 to extend the Edward Byrne Memorial Justice Assistance Grant Program through FY2020.</p> <p>HHS must advance education and awareness of the risk of abuse of prescription opioids (drugs with effects similar to opium).</p> <p>The Office of National Drug Control Policy (ONDCP), in coordination with HHS and the Department of Justice (DOJ), must establish a national drug awareness campaign that emphasizes the similarities between heroin and prescription opioids and increases awareness of the dangerous effects of mixing fentanyl (a prescription opioid painkiller) with heroin.</p> DOJ, in coordination with HHS and ONDCP, may make grants to state, local, or tribal governments to create demonstration programs to allow first responders to prevent opioid overdose death by administering an opioid overdose reversal drug (e.g., naloxone). Priority must be given to entities in states that provide civil liability protection for first responders administering a drug to counteract opioid overdoses.]]></text>
        </item>
      </billSummaries>
    </summaries>
    <title>Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015</title>
    <actions>
      <actionByCounts>
        <senate>2</senate>
      </actionByCounts>
      <actionTypeCounts>
        <referredToCommittee>1</referredToCommittee>
        <introducedInSenate>1</introducedInSenate>
      </actionTypeCounts>
      <item>
        <actionDate>2015-04-29</actionDate>
        <committee>
          <systemCode>ssju00</systemCode>
          <name>Judiciary Committee</name>
        </committee>
        <links />
        <sourceSystem>
          <name>Senate</name>
          <code>0</code>
        </sourceSystem>
        <text>Read twice and referred to the Committee on the Judiciary.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2015-04-29</actionDate>
        <actionCode>10000</actionCode>
        <type>IntroReferral</type>
        <links />
        <committee />
        <text>Introduced in Senate</text>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
      </item>
    </actions>
    <congress>114</congress>
    <version>1.0.0</version>
    <subjects>
      <billSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
        <legislativeSubjects>
          <item>
            <name>Advisory bodies</name>
          </item>
          <item>
            <name>Civil actions and liability</name>
          </item>
          <item>
            <name>Congressional oversight</name>
          </item>
          <item>
            <name>Crime prevention</name>
          </item>
          <item>
            <name>Drug therapy</name>
          </item>
          <item>
            <name>Drug trafficking and controlled substances</name>
          </item>
          <item>
            <name>Drug, alcohol, tobacco use</name>
          </item>
          <item>
            <name>Emergency medical services and trauma care</name>
          </item>
          <item>
            <name>First responders and emergency personnel</name>
          </item>
          <item>
            <name>Government information and archives</name>
          </item>
          <item>
            <name>Health programs administration and funding</name>
          </item>
          <item>
            <name>Health promotion and preventive care</name>
          </item>
          <item>
            <name>Law enforcement administration and funding</name>
          </item>
          <item>
            <name>Medical research</name>
          </item>
          <item>
            <name>Prescription drugs</name>
          </item>
        </legislativeSubjects>
      </billSubjects>
    </subjects>
    <originChamber>Senate</originChamber>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <createDate>2015-04-30T09:17:48Z</createDate>
    <sponsors>
      <item>
        <firstName>Kelly</firstName>
        <identifiers>
          <gpoId>8315</gpoId>
          <lisID>2075</lisID>
          <bioguideId>A000368</bioguideId>
        </identifiers>
        <party>R</party>
        <fullName>Sen. Ayotte, Kelly [R-NH]</fullName>
        <lastName>Ayotte</lastName>
        <state>NH</state>
        <bioguideId>A000368</bioguideId>
        <middleName />
        <byRequestType />
      </item>
    </sponsors>
    <cboCostEstimates />
    <committeeReports />
    <laws />
    <relatedBills>
      <item>
        <type>HR</type>
        <number>2805</number>
        <latestAction>
          <actionDate>2015-07-09</actionDate>
          <text>Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.</text>
        </latestAction>
        <congress>114</congress>
        <latestTitle>Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015</latestTitle>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <latestAction>
      <actionDate>2015-04-29</actionDate>
      <links />
      <text>Read twice and referred to the Committee on the Judiciary.</text>
    </latestAction>
    <introducedDate>2015-04-29</introducedDate>
    <billType>S</billType>
    <billNumber>1134</billNumber>
    <amendments />
    <updateDate>2018-06-02T06:46:23Z</updateDate>
    <titles>
      <item>
        <chamberCode />
        <parentTitleType />
        <title>Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015</title>
        <chamberName />
        <titleType>Short Titles as Introduced</titleType>
      </item>
      <item>
        <chamberCode />
        <parentTitleType />
        <title>A bill to address prescription opioid abuse and heroin use.</title>
        <chamberName />
        <titleType>Official Title as Introduced</titleType>
      </item>
      <item>
        <chamberCode />
        <parentTitleType />
        <title>Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015</title>
        <chamberName />
        <titleType>Display Title</titleType>
      </item>
    </titles>
    <recordedVotes />
    <calendarNumbers />
    <notes />
    <committees>
      <billCommittees>
        <item>
          <subcommittees />
          <systemCode>ssju00</systemCode>
          <chamber>Senate</chamber>
          <type>Standing</type>
          <name>Judiciary Committee</name>
          <activities>
            <item>
              <date>2015-04-29T20:05:29Z</date>
              <name>Referred to</name>
            </item>
          </activities>
        </item>
      </billCommittees>
    </committees>
    <cosponsors>
      <item>
        <identifiers>
          <gpoId>7941</gpoId>
          <lisID>1850</lisID>
          <bioguideId>D000607</bioguideId>
        </identifiers>
        <firstName>Joe</firstName>
        <sponsorshipWithdrawnDate />
        <party>D</party>
        <lastName>Donnelly</lastName>
        <bioguideId>D000607</bioguideId>
        <sponsorshipDate>2015-04-29</sponsorshipDate>
        <middleName />
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <fullName>Sen. Donnelly, Joe [D-IN]</fullName>
        <state>IN</state>
      </item>
    </cosponsors>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

